Skip to main content
Home

Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE),  American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA). 

RSS icon

  • heart doctors and surgeons working together. top cardiology hospitals in the United States.

    Medical societies respond after Trump administration questioned necessity of certain procedures

    A recent OIG report suggested many vascular surgeons, interventional cardiologists and interventional radiologists may be performing medically unnecessary vascular procedures in office-based labs. Now, some of the leading medical societies from those very fields have shared a statement to provide additional context. 

  • Cathie Biga, MSM, MACC, past president of the American College of Cardiology (ACC) and president/CEO of Cardiovascular Management of Illinois, explains some of the key consideration and strategic questions cardiologists should ask before signing a contract.

    What every cardiologist should consider before signing a contract

    Cathie Biga, MSN, a former ACC president, says salary is just one thing a cardiologist should ask about before signing any contract.

  • SAPT after TAVR linked to key benefits over DAPT, new data confirm

    All-cause mortality after six months was significantly lower for patients discharged on SAPT. That trend remained in place after 24 months.

  • Video of Mathew S. Maurer, MD, director, Cardiac Amyloidosis Program, NewYork Presbyterian Hospital, explains how the American Hearty Association’s ATTR Amyloidosis Initiative is bringing together multidisciplinary teams to strengthen management of transthyretin amyloid cardiomyopathy (ATTR-CM). The goal is to catch more of these patients earlier and ensure they get timely care before they end up in advanced heart failure. #ATTR #Cardiacamyloidosis

    American Heart Association takes on cardiac amyloidosis with new initiative

    One of the project's biggest goals is helping clinicians identify patients in need of care earlier than ever.

  • leg amputation below the knee

    Have clinicians been wrong about how they diagnose PAD?

    The ankle-brachial index, a noninvasive diagnostic test for peripheral artery disease, may provide even more value than clinicians previously realized. 

Heartflow Video

Physicians chime in: Coronary plaque staging offers more precise cardiac patient management

Sponsored by Heartflow

As precision cardiology continues to evolve, the integration of advanced coronary computed tomography angiography (CCTA) and AI-driven analysis is fundamentally changing how we assess and manage coronary artery disease (CAD). Here is a closer look at how Heartflow Plaque Staging is leveraging Total Plaque Volume (TPV) to stratify patient risk.

Society of cardiovascular computed tomography (SCCT) President Kavitha Chinnaiyan, MD, FACC, MSCCT, a cardiologist and professor of medicine at Oakland University William Beaumont School of Medicine in Royal Oak, with is part of Corewell Health, explains some of the key trends in coronary computed tomography angiography (CCTA) and how this is being translated into educational programming at the SCCT 2026 annual scientific meeting (ASM). #SCCT2026

SCCT President: Key trends in cardiac CT

As CCTA sees rapid adoption across cardiology, SCCT is working to address the education required to sustain the expansion.

cardiologist viewing heart data

TAVR or SAVR? Cardiologists and heart surgeons highlight the care that goes into each decision

When heart patients require aortic valve replacement, would they be a better fit for TAVR or SAVR? Such decisions are not made lightly, clinicians emphasized in a new joint statement.

cardiologists evaluating the human heart to provide a treatment strategy

Redo TAVR: Supra-annular, intra-annular valves linked to comparable outcomes

When a TAVR valve fails and that patient undergoes redo TAVR, are there benefits to choosing one device type over the other? The team behind a new study tracked multiple outcomes and identified specific factors that may help predict survival. 

HRS President, Mina Chung, MD, FHRS, staff cardiologist and Professor of Medicine in the Section of Pacing and Electrophysiology, Heart & Vascular Institute, Cleveland Clinic. Explains HRS accomplishments in the past year in terms of advocacy efforts and policy concerns impacting EP. #HRS2026 #EPeeps

Heart Rhythm 2026: Electrophysiologist Mina Chung discusses CPR, PFA and much more

Mina Chung, MD, who just concluded a one-year term as Heart Rhythm Society's president, spoke to Cardiovascular Business about successes from the past year as well as her goals for the future.

Heart Rhythm 2026 Program Chair Dhanunjaya "DJ" Lakkireddy, MD, MBA, FHRS, Executive Medical Director, Kansas City Heart Rhythm Institute, and professor of medicine at the University of Kansas Health System, offers an overview of key trends in electrophysiology (EP) technology.

PFA's dominance and other key electrophysiology trends on display at Heart Rhythm 2026

Heart Rhythm 2026 Program Chair DJ Lakkireddy, MD, spoke to Cardiovascular Business during the conference about several key EP trends. 

The Society for Cardiovascular Angiography and Interventions (SCAI) is entering a new chapter as Dawn Abbott, MD, MSCAI, who assumeed the presidency this week with a focus on strengthening the future of interventional cardiology through workforce development, expanded training pathways and continued efforts to broaden inclusion in the specialty. #SCAI2026 #SCAI26

New SCAI President Dawn Abbott outlines workforce training and inclusion priorities

SCAI President Dawn Abbott, MD, MSCAI, aims to turn attention toward the long-term sustainability of the interventional cardiology field.

Cordis acquires MedAlliance, known for its drug-eluting balloon technology, in deal that could surpass $1B

Fewer stents, positive outcomes: Sirolimus-eluting balloons a safe alternative during PCI

Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page 1
    • Page 2
    • Page 3
    • Current page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page Next ›
    • Last page Last »
Displaying 25 - 32 of 1536
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme